HemoCath Critical Care AI Platform

HemoCath pioneers advancements at the crossroads of Medtech and Digital Health, aiming to enhance care for patients in critical care and individuals with heart failure (HF) 


The versatile and scalable HemoCath™ AI Platform enables proactive AI-data-driven management of patients with acute HF from diagnosis to treatment and monitoring for all hospital heart procedures.


The user-friendly integrated Platform includes the HemoCath™ PA catheter securely connected to the Luc™ AI Cloud to continuously measure and monitor PAP & CVP, the leading indicators of heart congestion, allowing early targeted therapy. 

HemoCath PA Catheter

HemoCath™ pulmonary artery (PA) catheter measures PAP & CVP, the leading indicators of heart congestion.


Temporarily inserted into a brachial vein on the arm and positioned into the pulmonary artery. 


Substantially less invasive, more precise and easier-to-use compared to current PA catheters.  


PAP: pulmonary artery pressure
​CVP: central venous pressure 

Luc AI Cloud

HemoCath™ PA catheters are securely connected to the Luc™ AI Cloud for optimal monitoring of critical care and HF patients via AI

“Individually, the HemoCath PA catheter presents significant advantages to clinicians when compared to current PA catheters.

​

Combined with the Luc AI Cloud, the HemoCath Platform represents a groundbreaking advancement in tailoring cardiac care to suit the unique needs of every patient. 


Moreover, in the near future, the Platform will provide an invaluable database of precise clinical data for researchers ​and the heart failure industry.”


Melissa Fusari, MD
Physician Proctor, Edwards Lifesciences